|
⚲
|
| Keyboard |
| Bios Equity Cof LP | |
|---|---|
| Firm | BIOS Capital Management LP |
| Address | 1751 River Run Suite 400 Fort Worth, TX 76107 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| BIOS Capital Management LP | |||||
| BIOS I-Lumen Co-Invest I LP | 021-549023 | Director | 2.5 M | 6.7 M | |
| BIOS 2024 Co-Invest LP | 021-517482 | Director | 6.3 M | 16.1 M | |
| BIOS ONL Co-Invest II LP | 021-517476 | Director | 7.2 M | 7.7 M | |
| BIOS Clinical Opportunity Fund LP | 021-488788 | Director | 17.1 M of 50.0 M |
17.9 M | |
| BIOS 2026 Co-Invest LP | 021-577098 | Director | 3.4 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Actuate Therapeutics Inc ACTU
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
In8Bio Inc [INAB
Series B Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
In8Bio Inc [INAB
Series A Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
In8Bio Inc [INAB
Pre-Funded Warrants · derivative
|
2025-05-02 | Buy | 1,148,482 | ||
|
In8Bio Inc INAB
Series A Warrant · derivative
|
2024-10-04 | Grant | 574,241 | ||
|
In8Bio Inc INAB
Series A Warrant · derivative
|
2024-10-04 | Disposed to issuer | 574,241 | ||
|
In8Bio Inc INAB
Series C Warrant · derivative
|
2024-10-04 | Buy | 709,040 | ||
|
In8Bio Inc INAB
Pre-Funded Warrants · derivative
|
2024-10-04 | Buy | 709,040 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Buy | 375,000 | $8.00 | 3,000,000 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Buy | 125,000 | $8.00 | 1,000,000 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 525,797 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 307,538 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 141,457 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 462,073 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 61,857 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 153,702 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 54,032 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 176,499 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 23,628 | ||
| showing 20 of 65 most recent transactions | |||||